BioSpace News Archive

Quest Diagnostics and Allina Health announced a definitive agreement for Quest to acquire select laboratory assets from Allina Health, with the goal to improve access to and the affordability of innovative laboratory services across Minnesota and western Wisconsin.

Parallel Bio, a biotech company using the immune system to cure disease, today announced that Ari Gesher has joined as the first head of technology.

Medasense, a global leader in pain monitoring solutions, is proud to announce a strategic partnership with Nihon Kohden for the exclusive distribution of its revolutionary pain monitoring device in Japan.

Rivus Pharmaceuticals today announced publication of the rationale and design of the company’s Phase 2a HuMAIN trial in the European Journal of Heart Failure.

The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

Sona’s Chief Medical Officer and the Study’s principal investigator, Dr. Carman Giacomantonio, commented, “With two separate murine cancer models completed, we now believe it is clear that Sona’s THT therapy causes cancer specific proteins (cancer antigens) to become visible to the immune system.

By 2060, it’s estimated that 14 million people will be living with Alzheimer’s disease (AD), 40 percent of whom will experience psychotic symptoms.

Medpace Holdings, Inc. announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024.

CASI Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products, announced that the Company is planning to submit an Investigational New Drug application to the U.S. Food and Drug Administration for CID-103 for the treatment of antibody-mediated rejection in kidney transplant recipients by the end of 2024.

seqWell, a global provider of genomic library and multiplexing workflow solutions, announced the launch of their new portfolio of Tagify loaded-transposase reagents, including Tagify i5 UMI adapter-loaded Tn5.